Abilitatx
1 known investors
Abilita Therapeutics develops drug discovery technology focused on membrane protein targets using its EMP platform based on directed evolution principles.
Biotech
1 known investors
Abilita Therapeutics develops drug discovery technology focused on membrane protein targets using its EMP platform based on directed evolution principles.